Conclusion - Fungal Disease in Britain and the United States 1850–2000 - NCBI Bookshelf.pdf

In this book, we discuss the changing medical and public profile of fungal infections in the period 1850–2000. We consider four sets of diseases: ringworm and athlete’s foot (dermatophytosis); thrush or candidiasis (infection with Candida albicans); endemic, geographically specific infections in Nor...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Γλώσσα:English
Έκδοση: Springer Nature 2020
id oapen-20.500.12657-29947
record_format dspace
spelling oapen-20.500.12657-299472021-11-12T15:58:13Z Chapter Conclusion Homei, Aya Worboys, Michael candidiasis mycotoxins aspergillosis fungal infections dermatophytosis bic Book Industry Communication::M Medicine::MJ Clinical & internal medicine::MJC Diseases & disorders In this book, we discuss the changing medical and public profile of fungal infections in the period 1850–2000. We consider four sets of diseases: ringworm and athlete’s foot (dermatophytosis); thrush or candidiasis (infection with Candida albicans); endemic, geographically specific infections in North America (coccidioidomycosis, blastomycosis and histoplasmosis) and mycotoxins; and aspergillosis (infection with Aspergillus fumigatus). We discuss each disease in relation to developing medical knowledge and practices, and to social changes associated with ‘modernity’. Thus, mass schooling provided ideal conditions for the spread of ringworm of the scalp in children, and the rise of college sports and improvement of personal hygiene led to the spread of athlete’s foot. Antibiotics seemed to open the body to more serious Candida infections, as did new methods to treat cancers and the development of transplantation. Regional fungal infections in North America came to the fore due to the economic development of certain regions, where population movement brought in non-immune groups who were vulnerable to endemic mycoses. Fungal toxins or mycotoxins were discovered as by-products of modern food storage and distribution technologies. Lastly, the rapid development and deployment of new medical technologies, such as intensive care and immunosuppression in the last quarter of the twentieth century, increased the incidence of aspergillosis and other systemic mycoses. 2020-03-18 13:36:15 2020-04-01T12:40:32Z 2014-05-07 23:55 2020-03-18 13:36:15 2020-04-01T12:40:32Z 2020-04-01T12:40:32Z 2013 chapter 1000007 OCN: 1076788777 http://library.oapen.org/handle/20.500.12657/29947 eng Science, Technology and Medicine in Modern History application/pdf n/a Conclusion - Fungal Disease in Britain and the United States 1850–2000 - NCBI Bookshelf.pdf Springer Nature Fungal Disease in Britain and the United States 1850–2000 Palgrave Macmillan 6c6992af-b843-4f46-859c-f6e9998e40d5 f5b7784b-03ad-4c70-882a-ae023c1f5117 d859fbd3-d884-4090-a0ec-baf821c9abfd Wellcome Palgrave Macmillan 225 Basingstoke 1 074971 Wellcome Trust Wellcome open access
institution OAPEN
collection DSpace
language English
description In this book, we discuss the changing medical and public profile of fungal infections in the period 1850–2000. We consider four sets of diseases: ringworm and athlete’s foot (dermatophytosis); thrush or candidiasis (infection with Candida albicans); endemic, geographically specific infections in North America (coccidioidomycosis, blastomycosis and histoplasmosis) and mycotoxins; and aspergillosis (infection with Aspergillus fumigatus). We discuss each disease in relation to developing medical knowledge and practices, and to social changes associated with ‘modernity’. Thus, mass schooling provided ideal conditions for the spread of ringworm of the scalp in children, and the rise of college sports and improvement of personal hygiene led to the spread of athlete’s foot. Antibiotics seemed to open the body to more serious Candida infections, as did new methods to treat cancers and the development of transplantation. Regional fungal infections in North America came to the fore due to the economic development of certain regions, where population movement brought in non-immune groups who were vulnerable to endemic mycoses. Fungal toxins or mycotoxins were discovered as by-products of modern food storage and distribution technologies. Lastly, the rapid development and deployment of new medical technologies, such as intensive care and immunosuppression in the last quarter of the twentieth century, increased the incidence of aspergillosis and other systemic mycoses.
title Conclusion - Fungal Disease in Britain and the United States 1850–2000 - NCBI Bookshelf.pdf
spellingShingle Conclusion - Fungal Disease in Britain and the United States 1850–2000 - NCBI Bookshelf.pdf
title_short Conclusion - Fungal Disease in Britain and the United States 1850–2000 - NCBI Bookshelf.pdf
title_full Conclusion - Fungal Disease in Britain and the United States 1850–2000 - NCBI Bookshelf.pdf
title_fullStr Conclusion - Fungal Disease in Britain and the United States 1850–2000 - NCBI Bookshelf.pdf
title_full_unstemmed Conclusion - Fungal Disease in Britain and the United States 1850–2000 - NCBI Bookshelf.pdf
title_sort conclusion - fungal disease in britain and the united states 1850–2000 - ncbi bookshelf.pdf
publisher Springer Nature
publishDate 2020
_version_ 1771297431014604800